HUP0303864A3 - Pharmaceutical composition based on macrolides for topical application in ophthalmology and process for its preparation - Google Patents

Pharmaceutical composition based on macrolides for topical application in ophthalmology and process for its preparation

Info

Publication number
HUP0303864A3
HUP0303864A3 HU0303864A HUP0303864A HUP0303864A3 HU P0303864 A3 HUP0303864 A3 HU P0303864A3 HU 0303864 A HU0303864 A HU 0303864A HU P0303864 A HUP0303864 A HU P0303864A HU P0303864 A3 HUP0303864 A3 HU P0303864A3
Authority
HU
Hungary
Prior art keywords
macrolides
ophthalmology
preparation
pharmaceutical composition
topical application
Prior art date
Application number
HU0303864A
Other languages
English (en)
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Publication of HUP0303864A2 publication Critical patent/HUP0303864A2/hu
Publication of HUP0303864A3 publication Critical patent/HUP0303864A3/hu
Publication of HU230459B1 publication Critical patent/HU230459B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
HU0303864A 2001-04-12 2002-04-11 Makrolid alapú gyógyszerészeti készítmény szemészeti lokális alkalmazásra HU230459B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
FR01/05114 2001-04-12
PCT/FR2002/001263 WO2002083178A1 (fr) 2001-04-12 2002-04-11 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie

Publications (3)

Publication Number Publication Date
HUP0303864A2 HUP0303864A2 (hu) 2004-03-01
HUP0303864A3 true HUP0303864A3 (en) 2012-07-30
HU230459B1 HU230459B1 (hu) 2016-07-28

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303864A HU230459B1 (hu) 2001-04-12 2002-04-11 Makrolid alapú gyógyszerészeti készítmény szemészeti lokális alkalmazásra

Country Status (31)

Country Link
US (1) US7064109B2 (hu)
EP (1) EP1377316B1 (hu)
JP (2) JP4558275B2 (hu)
KR (1) KR100835002B1 (hu)
CN (1) CN1496270B (hu)
AR (1) AR034033A1 (hu)
AT (1) ATE397460T1 (hu)
BR (1) BRPI0208367B8 (hu)
CA (1) CA2443728C (hu)
CY (1) CY1108302T1 (hu)
CZ (1) CZ300213B6 (hu)
DE (1) DE60226962D1 (hu)
DK (1) DK1377316T3 (hu)
EA (1) EA008088B1 (hu)
EG (1) EG23169A (hu)
ES (1) ES2307754T3 (hu)
FR (1) FR2823441B1 (hu)
HK (1) HK1065708A1 (hu)
HR (1) HRP20030907B1 (hu)
HU (1) HU230459B1 (hu)
MA (1) MA27005A1 (hu)
MX (1) MXPA03009349A (hu)
OA (1) OA12462A (hu)
PA (1) PA8543401A1 (hu)
PE (1) PE20021082A1 (hu)
PL (1) PL204403B1 (hu)
PT (1) PT1377316E (hu)
SI (1) SI1377316T1 (hu)
TN (1) TNSN03091A1 (hu)
WO (1) WO2002083178A1 (hu)
ZA (1) ZA200307718B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE412400T1 (de) * 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
JP2010520210A (ja) * 2007-02-28 2010-06-10 アーシエックス セラピューティックス， インコーポレイテッド マイボーム腺分泌を正常化するための方法および組成物
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2394636B1 (en) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Method for treating retinal conditions using an intraocular tamponade
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
KR20190024983A (ko) * 2016-06-29 2019-03-08 오토노미, 인코포레이티드 트리글리세라이드 귀 제제 및 이의 용도
JOP20170147B1 (ar) * 2016-07-07 2021-08-17 Salvat Lab Sa تركيبة عينية تشتمل على زيت الخروع ودهون ثلاثية متوسطة السلسلة

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
PT925789E (pt) * 1997-12-02 2004-10-29 Pfizer Prod Inc Es oculares utilizacao de azitromicina no tratamento topico de infecco
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
EG23169A (en) 2004-06-30
DK1377316T3 (da) 2008-09-22
BR0208367B1 (pt) 2013-11-12
KR20030088466A (ko) 2003-11-19
AR034033A1 (es) 2004-01-21
CA2443728A1 (fr) 2002-10-24
BRPI0208367B8 (pt) 2021-05-25
PL363538A1 (en) 2004-11-29
HRP20030907B1 (en) 2010-04-30
ZA200307718B (en) 2004-09-02
EP1377316B1 (fr) 2008-06-04
CN1496270A (zh) 2004-05-12
BR0208367A (pt) 2004-03-09
CA2443728C (fr) 2011-01-04
US7064109B2 (en) 2006-06-20
HU230459B1 (hu) 2016-07-28
WO2002083178A1 (fr) 2002-10-24
PT1377316E (pt) 2008-09-15
PL204403B1 (pl) 2010-01-29
CZ300213B6 (cs) 2009-03-18
HUP0303864A2 (hu) 2004-03-01
US20040197340A1 (en) 2004-10-07
JP4558275B2 (ja) 2010-10-06
JP5170780B2 (ja) 2013-03-27
OA12462A (fr) 2006-06-24
EP1377316A1 (fr) 2004-01-07
FR2823441B1 (fr) 2004-09-10
PA8543401A1 (es) 2003-01-24
CY1108302T1 (el) 2014-02-12
EA008088B1 (ru) 2007-02-27
PE20021082A1 (es) 2002-12-18
ATE397460T1 (de) 2008-06-15
HRP20030907A2 (en) 2004-02-29
CZ20032771A3 (cs) 2004-01-14
SI1377316T1 (sl) 2008-10-31
JP2004526763A (ja) 2004-09-02
KR100835002B1 (ko) 2008-06-09
DE60226962D1 (de) 2008-07-17
JP2010043109A (ja) 2010-02-25
FR2823441A1 (fr) 2002-10-18
HK1065708A1 (en) 2005-03-04
ES2307754T3 (es) 2008-12-01
CN1496270B (zh) 2010-05-26
MA27005A1 (fr) 2004-12-20
TNSN03091A1 (fr) 2005-12-23
EA200301108A1 (ru) 2004-04-29
MXPA03009349A (es) 2004-11-12

Similar Documents

Publication Publication Date Title
HUP0302114A3 (en) Liquis pharmaceutical composition comprising erythropoietin protein, method for its preparation and its use
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0401935A3 (en) Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
AU2002352334A1 (en) Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
AU2001271055A1 (en) Pharmaceutical composition improved in peroral absorbability
HUP0301042A3 (en) Pharmaceutical composition useful in contraception
AU2002329022A1 (en) Method and pharmaceutical composition for treating inflammation
AU2578701A (en) Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
AU5326100A (en) Pharmaceutical compositions and methods for use
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
HUP0303864A3 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology and process for its preparation
CZ2006533A3 (cs) Amorfní ritonavir, způsoby jeho přípravy, jeho použití a farmaceutická kompozice ho obsahující
EE200300255A (et) Asitromütsiin monohüdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises
AU2001250423A1 (en) Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition
IL154240A0 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
AU5587800A (en) S-(+)-desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation
AU2003267848A1 (en) Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same
AU2001262928A1 (en) Pharmaceutical compositions and their use